Yeah sucks in situations like this, shareholders cop huge losses, but management who have been paid great salaries for years, get to just walk away with their salaries still paid, and start up at another biotech and do the whole thing again, gambling with others money. You would think they would atleast out of respect for holders that supported them through the cap raises, to have a plan or statement with optimism, not just utter dismal statements after the other with no hope.
Ann: Phase II Results, page-55
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
